KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Debt to Equity (2018 - 2021)

Historic Debt to Equity for BioNTech SE (BNTX) over the last 4 years, with Q4 2021 value amounting to $0.12.

  • BioNTech SE's Debt to Equity fell 4828.11% to $0.12 in Q4 2021 from the same period last year, while for Dec 2021 it was $0.12, marking a year-over-year decrease of 4828.11%. This contributed to the annual value of $0.12 for FY2021, which is 4828.11% down from last year.
  • Per BioNTech SE's latest filing, its Debt to Equity stood at $0.12 for Q4 2021, which was down 4828.11% from $0.22 recorded in Q4 2020.
  • BioNTech SE's 5-year Debt to Equity high stood at $0.23 for Q4 2018, and its period low was $0.12 during Q4 2021.
  • For the 4-year period, BioNTech SE's Debt to Equity averaged around $0.18, with its median value being $0.19 (2019).
  • In the last 5 years, BioNTech SE's Debt to Equity soared by 3848.62% in 2020 and then tumbled by 4828.11% in 2021.
  • Over the past 4 years, BioNTech SE's Debt to Equity (Quarter) stood at $0.23 in 2018, then plummeted by 31.37% to $0.16 in 2019, then soared by 38.49% to $0.22 in 2020, then plummeted by 48.28% to $0.12 in 2021.
  • Its Debt to Equity stands at $0.12 for Q4 2021, versus $0.22 for Q4 2020 and $0.16 for Q4 2019.